Patient-derived stem cells could improve drug research for Parkinson's

ALL ADSENSE ADS DISABLED -->
Researchers have taken a step toward personalized medicine for Parkinson's disease, by investigating signs of the disease in patient-derived cells and testing how the cells respond to drug treatments. The study was funded by the National Institutes of Health. The researchers collected skin cells from patients with genetically inherited forms of Parkinson's and reprogrammed those cells into ...

0 Comments